Landau Jeffrey B has filed 7 insider transactions across 1 company since January 2024.
Most recent transaction: a option exercise of 11250 shares of CytomX Therapeutics, Inc. ($CTMX) on August 20, 2024.
Activity breakdown: 0 open-market purchases and 2 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 20, 2024 | CytomX Therapeutics, Inc. | $CTMX | Landau Jeffrey B | Chief Business Officer | M | Common Stock | 11250 | $0.00 | 130,917.0000 | 0 | 9.40% | 0.00% |
| Aug. 20, 2024 | CytomX Therapeutics, Inc. | $CTMX | Landau Jeffrey B | Chief Business Officer | S | Common Stock | 4181 | $1.23 | 126,736.0000 | 0 | 3.19% | 0.00% |
| Aug. 20, 2024 | CytomX Therapeutics, Inc. | $CTMX | Landau Jeffrey B | Chief Business Officer | M | Performance Stock Units (PSUs) | 11250 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| March 19, 2024 | CytomX Therapeutics, Inc. | $CTMX | Landau Jeffrey B | Chief Business Officer | S | Common Stock | 6562 | $2.09 | 117,740.0000 | 0 | 5.28% | 0.00% |
| Jan. 18, 2024 | CytomX Therapeutics, Inc. | $CTMX | Landau Jeffrey B | Chief Business Officer | A | Common Stock | 30000 | $0.00 | 124,302.0000 | 0 | 31.81% | 0.00% |
| Jan. 18, 2024 | CytomX Therapeutics, Inc. | $CTMX | Landau Jeffrey B | Chief Business Officer | A | Stock Option (Right to Buy) | 140000 | $0.00 | 140,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 18, 2024 | CytomX Therapeutics, Inc. | $CTMX | Landau Jeffrey B | Chief Business Officer | A | Performance Stock Units (PSUs) | 75000 | $0.00 | 75,000.0000 | 0 | 9999.99% | 0.00% |